Giving another chance to mifepristone in pharmacotherapy for aggressive meningiomas-A likely synergism with hydroxyurea?
Department of Neurosurgery, Memorial Hospital, Istanbul, Turkey.
İlhan
İ
Elmaci
Department of Immunology, Experimental Medical Research Institute/DETAE, Istanbul University, Istanbul, Turkey. Electronic address: maltinoz@gmail.com.
Meric A
MA
Altinoz
Nisantasi Neuropathology Group, Istanbul, Turkey.
Aydin
A
Sav
Department of Pharmacology, Cerrahpasa Faculty of Medicine, Istanbul University, Turkey.
Zeliha
Z
Yazici
Department of Biochemistry, Acibadem University, Istanbul, Turkey.
Aysel
A
Ozpinar
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D008577:Meningeal Neoplasms / Q000188:drug therapy*; D008579:Meningioma / Q000188:drug therapy*; D015735:Mifepristone / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D015735:Mifepristone; D006918:Hydroxyurea